CandlesenseCandlesense
AVXLClinical Trials•globenewswire•

Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease

Sentiment:Positive (70)

Summary

Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 20, 2025 by globenewswire

← Back to AVXL News
    Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease | AVXL Stock News | Candlesense